Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2025 Financial Results and Business Updates

Intellia Therapeutics (Nasdaq: NTLA) will host a conference call on February 26, 2026 at 8:00 a.m. ET to discuss fourth-quarter and full-year 2025 financial results and business updates.

Rhea-AI Summary

Intellia Therapeutics (Nasdaq: NTLA) will host a conference call on February 26, 2026 at 8:00 a.m. ET to discuss fourth-quarter and full-year 2025 financial results and business updates.

Investors may join via webcast or teleconference; a replay will be available for approximately 90 days on the company’s Events page.

Argus Feb 19 session

+4.49% close to close 0.4x rel. volume Open Argus

Details

News Market Reaction – NTLA

On Feb 19, the day this news came out, NTLA closed 4.49% above the previous close.

Data tracked by StockTitan Argus for the Feb 19 session.

Key Figures

Conference date: February 26, 2026 Conference time: 8 a.m. ET U.S. dial-in: 1-833-316-0545 +2 more

Conference date

February 26, 2026

Scheduled earnings and business update call

Conference time

8 a.m. ET

Start time for Q4 and full-year 2025 call

U.S. dial-in

1-833-316-0545

Domestic teleconference access number

International dial-in

1-412-317-5726

International teleconference access number

Replay duration

90 days

Replay availability on the company’s website

Previous Conferences,earnings Reports

5 past events · Latest: Jul 31

Same Type 5 events

1. Jul 31

   Earnings call scheduling

   24h Move

   -5.6%

   Announced Q2 2025 earnings call date and access details.

2. May 01

   Earnings call scheduling

   24h Move

   -2.6%

   Announced Q1 2025 earnings call timing and participation info.

3. Feb 20

   Earnings call scheduling

   24h Move

   -0.2%

   Set date for Q4 and full-year 2024 results call.

4. Aug 01

   Earnings call scheduling

   24h Move

   -4.1%

   Announced Q2 2024 earnings and updates conference call.

5. May 02

   Earnings call scheduling

   24h Move

   +3.4%

   Outlined Q1 2024 results call focused on CRISPR programs.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

clinical-stage, gene editing, CRISPR-based therapies, webcast, +1 more

5 terms

clinical-stage medical

"a leading clinical-stage gene editing company focused on revolutionizing medicine"

Clinical-stage describes a drug, therapy, or company whose product is being tested in human trials but has not yet received regulatory approval. For investors, it signals that the project has moved beyond lab work into real-world testing—meaning higher potential reward if trials succeed but also clear risks from trial setbacks, costs, and regulatory delay; think of it like a prototype car on public road tests that could either prove its value or reveal problems that stop it from reaching production.

gene editing medical

"a leading clinical-stage gene editing company focused on revolutionizing medicine"

Gene editing is a set of laboratory techniques that change the DNA inside living cells to add, remove, or alter specific genes, like using precise 'cut-and-paste' tools to edit an instruction manual for a living organism. It matters to investors because successful edits can produce new therapies, improve agricultural products, or create commercial advantages; progress, safety, regulatory approvals, and patent control all affect a company’s value and risk profile.

CRISPR-based therapies medical

"company focused on revolutionizing medicine with CRISPR-based therapies"

CRISPR-based therapies are medical treatments that use a precise, programmable tool to find and change specific bits of a patient’s DNA, like using molecular scissors to edit a line in a recipe. They matter to investors because successful edits can potentially cure inherited or hard-to-treat diseases, offering high commercial upside, but they also carry long development timelines, regulatory hurdles, safety uncertainties, and manufacturing and intellectual-property risks that affect valuation.

webcast technical

"To join a webcast of the call, please visit this link."

A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.

teleconference technical

"To join the teleconference, U.S. callers should dial 1-833-316-0545"

A teleconference is a live meeting held over phone or internet where company leaders, analysts, and investors join from different locations to share information and answer questions. For investors it matters because these sessions reveal management’s plans, performance details and tone—similar to listening in on a boardroom briefing—so they can reassess a company’s outlook and make better buy, hold, or sell decisions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that the company will host a conference call on February 26, 2026, at 8 a.m. ET to discuss its fourth quarter and full-year 2025 financial results and business updates.

To join a webcast of the call, please visit this link. To join the teleconference, U.S. callers should dial 1-833-316-0545 and international callers should dial 1-412-317-5726, approximately five minutes before the call. All participants should ask to be connected to the Intellia Therapeutics conference call.

A replay of the call will be available for approximately 90 days on the Events page in the Investors & Media section of Intellia’s website, www.intelliatx.com.

About Intellia Therapeutics

Intellia Therapeutics, Inc. (Nasdaq: NTLA) is a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies. Since its inception, Intellia has focused on leveraging gene editing technology to develop novel, first-in-class medicines that address important unmet medical needs and advance the treatment paradigm for patients. Intellia’s deep scientific, technical and clinical development experience, along with its people, is helping set the standard for a new class of medicine. To harness the full potential of gene editing, Intellia continues to expand the capabilities of its CRISPR-based platform with novel editing and delivery technologies. Learn more at intelliatx.com and follow us @intelliatx.

Intellia Contact:

Jason Fredette
Vice President, Investor Relations and Corporate Communications
jason.fredette@intelliatx.com

This press release was published by a CLEAR® Verified individual.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Intellia Therapeutics (NTLA) holding its Q4 and full-year 2025 results call?

The call is scheduled for February 26, 2026 at 8:00 a.m. ET. According to the company, the discussion will cover fourth-quarter and full-year 2025 financial results and business updates with a subsequent replay available for about 90 days.

How can investors access the Intellia Therapeutics (NTLA) earnings webcast on February 26, 2026?

Investors can join the live webcast via the company’s Events page on its investor website. According to the company, the webcast link will host the live audio and a replay will be posted for approximately 90 days.

What phone numbers should I use to join Intellia Therapeutics (NTLA) teleconference on Feb 26, 2026?

U.S. callers should dial 1-833-316-0545; international callers should dial 1-412-317-5726. According to the company, callers should dial about five minutes early and request connection to the Intellia Therapeutics conference call.

Will there be a replay of the Intellia Therapeutics (NTLA) February 26, 2026 call and where is it available?

Yes. A replay will be available for approximately 90 days on the company’s Events page in the Investors & Media section. According to the company, the replay will include the full call audio after the live event concludes.

What topics will Intellia Therapeutics (NTLA) cover in the February 26, 2026 call?

The company will discuss fourth-quarter and full-year 2025 financial results and business updates. According to the company, management will present results and provide updates on corporate and clinical developments relevant to investors.